Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- V2550 - Provider product page
- Provider
- NSJ Bioreagents
- Product name
- ABO Antibody / Blood Group Antigen A
- Antibody type
- Monoclonal
- Description
- This highly specific ABO antibody is suitable for use in IH/Immunofluorescence applications with human samples.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antibody clone number
- HE-193
- Vial size
- 20 ug (with BSA and sodium azide), 100 ug (with BSA and sodium azide), 100 ug (without BSA or sodium azide), 7 ml IHC only format (if applicable)
- Concentration
- 0.2 mg/ml, 1 mg/ml
- Storage
- Store the ABO antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Submitted references Characterization of moose intestinal glycosphingolipids.
Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts.
Structural complexity of non-acid glycosphingolipids in human embryonic stem cells grown under feeder-free conditions.
Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation.
Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells.
Johansson MM, Dedic B, Lundholm K, Branzell FB, Barone A, Benktander J, Teneberg S
Glycoconjugate journal 2015 Aug;32(6):393-412
Glycoconjugate journal 2015 Aug;32(6):393-412
Characterization of acid and non-acid glycosphingolipids of porcine heart valve cusps as potential immune targets in biological heart valve grafts.
Barone A, Benktander J, Teneberg S, Breimer ME
Xenotransplantation 2014 Nov-Dec;21(6):510-22
Xenotransplantation 2014 Nov-Dec;21(6):510-22
Structural complexity of non-acid glycosphingolipids in human embryonic stem cells grown under feeder-free conditions.
Barone A, Benktander J, Ångström J, Aspegren A, Björquist P, Teneberg S, Breimer ME
The Journal of biological chemistry 2013 Apr 5;288(14):10035-50
The Journal of biological chemistry 2013 Apr 5;288(14):10035-50
Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation.
Tanabe T, Ishida H, Horita S, Yamaguchi Y, Toma H, Tanabe K
Transplant immunology 2011 Jul;25(1):1-6
Transplant immunology 2011 Jul;25(1):1-6
Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells.
Mölne J, Björquist P, Andersson K, Diswall M, Jeppsson A, Strokan V, Rydberg L, Breimer ME
Transplantation 2008 Nov 27;86(10):1407-13
Transplantation 2008 Nov 27;86(10):1407-13
No comments: Submit comment
Supportive validation
- Submitted by
- NSJ Bioreagents (provider)
- Main image
- Experimental details
- IHC testing of formalin-fixed, paraffin-embedded human colon carcinoma stained with Blood Group Antigen A antibody (HE-193)
